YOLFTbeta
Pulmatrix Inc

Pulmatrix Inc

PULM · NASDAQ · Healthcare / Biotechnology

1.29USD-0.01 (-0.76%)

Price History

Full chart

Market Stats

Previous Close1.30
Open1.27
Day Range1.25 – 1.30
52-Week Range1.16 – 5.50
Volume5.73K
Market Cap5.88M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.10
Dividend Yield0.00%
Beta1.90
50-Day Avg1.57
200-Day Avg1.90

About

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Peter Ludlum CMA, MBA
  • Employees2
  • Headquarters945 Concord Street, Framingham, MA, United States, 01701, USA
  • Websitehttps://www.pulmatrix.com

Leadership

  • Mr. Peter Ludlum CMA, MBAInterim CEO & Interim CFO · b. 1955
  • Dr. Alexander M. Klibanov Ph.D.Founder · b. 1950

Financials

Income Statement

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-653.00K352.00K352.00K1.20M835.00K335.00K153.00K7.91M12.63M5.17M6.07M7.30M7.81M0
Growth (%)---46.09%0.00%+241.19%-30.47%-59.88%-54.33%+5069.93%+59.72%-59.09%+17.45%+20.21%+6.96%-100.00%
Cost of Revenue-8.56M6.59M6.59M7.19M10.15M10.24M12.97M12.85M-15.38M1.54M15.52M7.17M38.00K
Gross Profit--7.91M-6.24M-6.24M-5.99M-9.32M-9.91M-12.81M-4.93M12.63M-10.21M6.07M-8.22M640.00K-38.00K
Gross Margin--1211.49%-1772.16%-1772.16%-498.42%-1115.81%-2957.61%-8374.51%-62.39%100.00%-197.58%100.00%-112.63%8.20%-
Operating Expense--7.39M-3.12M2.84M17.03M15.55M7.57M7.52M15.76M22.50M9.95M25.02M6.52M10.40M5.13M
Operating Income-30.00K-523.00K-3.12M-9.08M-23.02M-24.87M-17.48M-20.33M-20.69M-9.86M-20.17M-18.95M-14.74M-9.76M-5.17M
Operating Margin--80.09%-885.80%-2578.41%-1916.57%-2977.96%-5216.42%-13288.24%-261.59%-78.06%-390.15%-312.09%-201.97%-125.07%-
EBITDA-30.00K-523.00K-3.12M-8.73M-15.39M-17.08M-17.23M-20.08M-13.24M-9.65M-16.42M-17.40M-13.99M-7.04M-5.16M
EBITDA Margin--80.09%-885.23%-2481.25%-1281.10%-2045.75%-5142.99%-13122.88%-167.41%-76.36%-317.68%-286.64%-191.66%-90.17%-
Net Income-30.00K-523.00K-3.12M-24.14M-26.17M-27.84M-18.06M-20.56M-20.60M-19.31M-20.17M-18.73M-14.12M-9.56M-5.16M
Net Income Margin--80.09%-885.80%-6859.09%-2178.77%-3334.49%-5389.85%-13439.87%-260.38%-152.83%-390.23%-308.43%-193.49%-122.46%-
R&D20.00K258.00K1.38M6.59M7.19M17.69M10.24M12.97M12.85M15.61M15.38M18.24M15.52M7.17M38.00K
R&D as % of Total Revenue-39.51%392.61%1872.16%598.42%2118.08%3057.61%8474.51%162.39%123.55%297.58%300.44%212.63%91.80%-
Interest Expense0000953.00K881.00K643.00K186.00K186.00K04.00K111.00K---
Interest Expense % of Total Revenue-0.00%0.00%0.00%79.35%105.51%191.94%121.57%2.35%0.00%0.08%1.83%---

Balance Sheet

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-148.00K15.58M15.58M44.87M16.66M15.98M14.72M36.10M38.17M58.82M40.95M33.96M9.94M4.14M
Total Liabilities-101.00K947.00K947.00K12.27M7.90M5.84M2.88M25.08M15.03M11.37M9.84M15.96M996.00K329.00K
Total Equity-28.00K47.00K14.63M14.63M32.61M8.76M10.14M11.84M11.02M23.14M47.45M31.11M18.00M8.95M3.81M
Cash-96.00K15.57M15.57M18.90M4.18M3.55M2.56M23.44M31.66M53.84M35.63M19.17M9.52M4.09M
Total Debt-27.56M-39.70M6.72M5.80M3.22M-675.00K1.74M2.29M857.00K8.76M--
Net Debt-27.46M-15.57M24.13M-12.18M1.62M-329.00K-2.56M-22.77M-29.91M-51.55M-34.77M-10.42M-9.52M-4.09M

Cash Flow

Currency: USD2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-30.00K-426.00K-2.97M-2.97M-12.47M-13.24M-14.48M-16.76M3.23M-12.48M-19.73M-19.36M-15.98M-10.72M-5.43M
Investing Cash Flow--4.00K--156.00K9.40M-431.00K-74.00K-19.00K-58.00K-281.00K-144.00K-86.00K-676.00K-398.00K-
Financing Cash Flow30.00K526.00K18.44M18.44M21.52M-1.05M13.92M15.79M17.70M20.98M43.48M1.23M53.00K0-
Capital Expenditure04.00K0156.00K266.00K455.00K74.00K19.00K58.00K281.00K144.00K86.00K676.00K398.00K0
Free Cash Flow-30.00K-430.00K-2.97M-3.13M-12.74M-13.70M-14.55M-16.78M3.17M-12.76M-19.87M-19.44M-16.66M-11.11M-5.43M
Dividends Paid---0000---3.20M----
FCF to OCF100.00%100.94%100.00%105.25%102.13%103.44%100.51%100.11%98.20%102.25%100.73%100.44%104.23%103.71%100.00%
Dividend Paid to FCF---0.00%0.00%0.00%0.00%----16.09%----

Earnings

Report DateJul 1, 2014Nov 13, 2014Jun 29, 2015Aug 14, 2015Nov 12, 2015May 5, 2016Aug 4, 2016Nov 4, 2016Mar 10, 2017May 5, 2017Aug 4, 2017Nov 9, 2017Mar 13, 2018May 11, 2018Aug 3, 2018Nov 14, 2018Feb 19, 2019May 15, 2019Aug 5, 2019Nov 1, 2019Mar 26, 2020May 14, 2020Aug 7, 2020Nov 12, 2020Mar 23, 2021May 11, 2021Aug 10, 2021Nov 10, 2021Mar 29, 2022May 12, 2022Aug 10, 2022Nov 10, 2022Mar 30, 2023May 12, 2023Aug 10, 2023Nov 9, 2023Mar 28, 2024May 10, 2024Aug 13, 2024Nov 7, 2024Mar 26, 2025May 15, 2025Aug 6, 2025Oct 16, 2025Feb 26, 2026May 19, 2026Aug 13, 2026Oct 15, 2026
EPS Estimate-0.00---------60.00-60.00-53.00-0.19-37.00-36.00-24.00-11.80-7.80-6.80-5.40-4.40-7.60-4.40-3.80-2.00-1.80-1.40-1.60-1.41-1.51-1.51-1.44-1.22-1.23-1.05-1.040.23----0.000.00----
EPS Actual-230.300.00-283.12-26.56-3.12-3.80-6.21-2.10-6.62-2.10-58.00-44.00-42.00-0.24-26.00-20.00-15.00-11.99-1.43-3.60-3.20-4.60-1.00-6.20-1.00-1.80-1.40-1.64-2.43-1.51-1.36-1.45-1.14-1.22-1.04-1.03-0.570.23-1.59-0.71-0.54-0.50-0.42-0.24-0.25-0.32-0.29-
Surprise----------3.33%26.67%20.75%-26.32%29.73%44.44%37.50%-1.61%81.67%47.06%40.74%-4.55%86.84%-40.91%73.68%10.00%22.22%-17.14%-51.88%-7.09%9.93%3.97%20.83%0.00%15.45%1.90%45.19%-1.78%----------
Timing---Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-------

Key Statistics & Ratios

Market Cap5.88M
Enterprise Value-3.37M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales48.20
Price / Book3.87
EPS-1.10
Book Value0.436
Revenue (TTM)3.00K
Gross Profit (TTM)-38.00K
EBITDA-5.06M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-98.35%
Return on Assets-54.69%
Shares Outstanding3.65M
Shares Float3.65M
Beta1.90
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 10.00
  • Buy
    1

Ownership Breakdown

Institutions
9.16%
Insiders
0.78%
Retail / Other
90.06%

Top Institutional Holders

  • Renaissance Technologies Corp
    109.15K2.99%
  • BlackRock Inc
    54.90K1.50%
  • Geode Capital Management, LLC
    44.63K1.22%
  • Vanguard Capital Management, LLC
    33.59K0.92%
  • SBI Securities Co Ltd
    30.09K0.82%
  • Vanguard Fiduciary Trust Co
    14.71K0.40%
  • Jane Street Group LLC
    14.58K0.40%
  • State Street Corp
    13.95K0.38%
  • XTX Topco Ltd
    13.67K0.37%
  • Tower Research Capital LLC
    2070.01%
  • UBS Group AG
    230.00%
  • Royal Bank of Canada
    70.00%
  • Hanson Mcclain Inc
    30.00%
  • Northwestern Mutual Wealth Management Co
    10.00%
  • DRW Securities, LLC
    00.00%
  • FLAGSHIP HARBOR ADVISORS, LLC
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    18.22K0.50%
  • Fidelity Series Total Market Index
    5.23K0.14%
  • Fidelity Total Market Index
    4.43K0.12%
  • Fidelity Nasdaq Composite Index
    3.15K0.09%

Stock Splits

  • Mar 1, 20221:20
  • Feb 6, 20191:10
  • Jun 16, 20154:10